{"entity":{"type":"insider","cik":"0001566083","url":"/insider/0001566083","json_url":"/insider/0001566083.json","name":"Prange Karen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":12,"first":"2014-12-10","last":"2026-08-07","span_basis":"filed_date"},"name_variants":[{"name":"Prange Karen","source":"filing","n_filings":12,"first_seen":"2014-12-10","last_seen":"2026-08-07"}],"transactions":[{"id":5756624,"accession":"0001566083-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001566083-26-000006","line_url":"/filing/0001566083-26-000006#line-1","is_derivative":false,"issuer_cik":"0001323885","issuer_name":"AtriCure, Inc.","issuer_ticker":"ATRC","issuer_name_source":null,"issuer_url":"/issuer/0001323885","owner_cik":"0001566083","owner_name":"Prange Karen","owner_display_name":"Prange Karen","owner_url":"/insider/0001566083","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3564.0,"shares_display":"3,564","price_per_share":38.8,"price_display":"38.80","price_state":"stated","total_value":138283.2,"total_display":"138,283.20","total_whole":"138,283","shares_owned_after":22809.0,"shares_owned_after_display":"22,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-05","filed_date":"2026-08-07","scope":"insider"},{"id":5824518,"accession":"0001566083-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001566083-26-000004","line_url":"/filing/0001566083-26-000004#line-1","is_derivative":false,"issuer_cik":"0001323885","issuer_name":"AtriCure, Inc.","issuer_ticker":"ATRC","issuer_name_source":null,"issuer_url":"/issuer/0001323885","owner_cik":"0001566083","owner_name":"Prange Karen","owner_display_name":"Prange Karen","owner_url":"/insider/0001566083","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":28.65,"price_display":"28.65","price_state":"stated","total_value":85950.0,"total_display":"85,950.00","total_whole":"85,950","shares_owned_after":26373.0,"shares_owned_after_display":"26,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-20","filed_date":"2026-05-22","scope":"insider"},{"id":4106951,"accession":"0001323885-25-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001323885-25-000027","line_url":"/filing/0001323885-25-000027#line-1","is_derivative":false,"issuer_cik":"0001323885","issuer_name":"AtriCure, Inc.","issuer_ticker":"ATRC","issuer_name_source":null,"issuer_url":"/issuer/0001323885","owner_cik":"0001566083","owner_name":"Prange Karen","owner_display_name":"Prange Karen","owner_url":"/insider/0001566083","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6100.0,"shares_display":"6,100","price_per_share":38.12,"price_display":"38.12","price_state":"stated","total_value":232532.0,"total_display":"232,532.00","total_whole":"232,532","shares_owned_after":17828.0,"shares_owned_after_display":"17,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":8129594,"accession":"0001628280-23-025327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-23-025327","line_url":"/filing/0001628280-23-025327#line-2","is_derivative":false,"issuer_cik":"0001566083","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001566083","owner_cik":"0001566083","owner_name":"Prange Karen","owner_display_name":"Prange Karen","owner_url":"/insider/0001566083","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37600.0,"shares_display":"37,600","price_per_share":0.051,"price_display":"0.05","price_state":"stated","total_value":1917.6,"total_display":"1,917.60","total_whole":"1,918","shares_owned_after":8799.0,"shares_owned_after_display":"8,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-21","filed_date":"2023-07-21","scope":"insider"},{"id":8129593,"accession":"0001628280-23-025327","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-025327","line_url":"/filing/0001628280-23-025327#line-1","is_derivative":false,"issuer_cik":"0001566083","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001566083","owner_cik":"0001566083","owner_name":"Prange Karen","owner_display_name":"Prange Karen","owner_url":"/insider/0001566083","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91866.0,"shares_display":"91,866","price_per_share":0.075,"price_display":"0.08","price_state":"stated","total_value":6889.95,"total_display":"6,889.95","total_whole":"6,890","shares_owned_after":46399.0,"shares_owned_after_display":"46,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-21","scope":"insider"},{"id":8477728,"accession":"0001323885-23-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001323885-23-000075","line_url":"/filing/0001323885-23-000075#line-1","is_derivative":false,"issuer_cik":"0001323885","issuer_name":"AtriCure, Inc.","issuer_ticker":"ATRC","issuer_name_source":null,"issuer_url":"/issuer/0001323885","owner_cik":"0001566083","owner_name":"Prange Karen","owner_display_name":"Prange Karen","owner_url":"/insider/0001566083","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":713.0,"shares_display":"713","price_per_share":47.89,"price_display":"47.89","price_state":"stated","total_value":34145.57,"total_display":"34,145.57","total_whole":"34,146","shares_owned_after":16140.0,"shares_owned_after_display":"16,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-12","scope":"insider"},{"id":6310936,"accession":"0001628280-22-013939","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-22-013939","line_url":"/filing/0001628280-22-013939","is_derivative":false,"issuer_cik":"0001566083","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001566083","owner_cik":"0001566083","owner_name":"Prange Karen","owner_display_name":"Prange Karen","owner_url":"/insider/0001566083","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":37600.0,"shares_display":"37,600","price_per_share":2.6596143617021277,"price_display":"2.66","price_state":"stated","total_value":100001.5,"total_display":"100,001.50","total_whole":"100,002","shares_owned_after":83754.0,"shares_owned_after_display":"83,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-12","scope":"insider","n_lines":3},{"id":2381351,"accession":"0001225208-16-029417","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-16-029417","line_url":"/filing/0001225208-16-029417#line-1","is_derivative":false,"issuer_cik":"0000885725","issuer_name":"BOSTON SCIENTIFIC CORP","issuer_ticker":"BSX","issuer_name_source":null,"issuer_url":"/issuer/0000885725","owner_cik":"0001566083","owner_name":"Prange Karen","owner_display_name":"Prange Karen","owner_url":"/insider/0001566083","role":"Officer (SVP&Pres, Uro & Pelvic Health)","role_mark":"O","role_mark_label":"Officer (SVP&Pres, Uro & Pelvic Health)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP&Pres, Uro & Pelvic Health","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14747.0,"shares_display":"14,747","price_per_share":17.2746,"price_display":"17.27","price_state":"stated","total_value":254748.5262,"total_display":"254,748.53","total_whole":"254,749","shares_owned_after":38395.0,"shares_owned_after_display":"38,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-08","filed_date":"2016-03-08","scope":"insider"},{"id":3219988,"accession":"0001225208-16-025905","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-16-025905","line_url":"/filing/0001225208-16-025905#line-1","is_derivative":false,"issuer_cik":"0000885725","issuer_name":"BOSTON SCIENTIFIC CORP","issuer_ticker":"BSX","issuer_name_source":null,"issuer_url":"/issuer/0000885725","owner_cik":"0001566083","owner_name":"Prange Karen","owner_display_name":"Prange Karen","owner_url":"/insider/0001566083","role":"Officer (SVP&Pres, Uro & Pelvic Health)","role_mark":"O","role_mark_label":"Officer (SVP&Pres, Uro & Pelvic Health)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP&Pres, Uro & Pelvic Health","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6216.0,"shares_display":"6,216","price_per_share":16.053,"price_display":"16.05","price_state":"stated","total_value":99785.448,"total_display":"99,785.45","total_whole":"99,785","shares_owned_after":23647.0,"shares_owned_after_display":"23,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-08","filed_date":"2016-02-09","scope":"insider"},{"id":8547653,"accession":"0001225208-15-015247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-15-015247","line_url":"/filing/0001225208-15-015247#line-1","is_derivative":false,"issuer_cik":"0000885725","issuer_name":"BOSTON SCIENTIFIC CORP","issuer_ticker":"BSX","issuer_name_source":null,"issuer_url":"/issuer/0000885725","owner_cik":"0001566083","owner_name":"Prange Karen","owner_display_name":"Prange Karen","owner_url":"/insider/0001566083","role":"Officer (SVP&Pres, Uro & Women's Health)","role_mark":"O","role_mark_label":"Officer (SVP&Pres, Uro & Women's Health)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP&Pres, Uro & Women's Health","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17456.0,"shares_display":"17,456","price_per_share":17.662,"price_display":"17.66","price_state":"stated","total_value":308307.872,"total_display":"308,307.87","total_whole":"308,308","shares_owned_after":17430.0,"shares_owned_after_display":"17,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-07","filed_date":"2015-07-07","scope":"insider"},{"id":8546668,"accession":"0001225208-15-006767","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-15-006767","line_url":"/filing/0001225208-15-006767#line-1","is_derivative":false,"issuer_cik":"0000885725","issuer_name":"BOSTON SCIENTIFIC CORP","issuer_ticker":"BSX","issuer_name_source":null,"issuer_url":"/issuer/0000885725","owner_cik":"0001566083","owner_name":"Prange Karen","owner_display_name":"Prange Karen","owner_url":"/insider/0001566083","role":"Officer (SVP&Pres, Uro & Women's Health)","role_mark":"O","role_mark_label":"Officer (SVP&Pres, Uro & Women's Health)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP&Pres, Uro & Women's Health","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2492.0,"shares_display":"2,492","price_per_share":16.7888,"price_display":"16.79","price_state":"stated","total_value":41837.6896,"total_display":"41,837.69","total_whole":"41,838","shares_owned_after":17430.0,"shares_owned_after_display":"17,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-03","filed_date":"2015-03-04","scope":"insider"},{"id":8261698,"accession":"0001225208-15-006312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-15-006312","line_url":"/filing/0001225208-15-006312#line-1","is_derivative":false,"issuer_cik":"0000885725","issuer_name":"BOSTON SCIENTIFIC CORP","issuer_ticker":"BSX","issuer_name_source":null,"issuer_url":"/issuer/0000885725","owner_cik":"0001566083","owner_name":"Prange Karen","owner_display_name":"Prange Karen","owner_url":"/insider/0001566083","role":"Officer (SVP&Pres, Uro & Women's Health)","role_mark":"O","role_mark_label":"Officer (SVP&Pres, Uro & Women's Health)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP&Pres, Uro & Women's Health","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1307.0,"shares_display":"1,307","price_per_share":16.8043,"price_display":"16.80","price_state":"stated","total_value":21963.2201,"total_display":"21,963.22","total_whole":"21,963","shares_owned_after":17430.0,"shares_owned_after_display":"17,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-27","filed_date":"2015-03-02","scope":"insider"},{"id":6918390,"accession":"0001225208-14-024738","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-14-024738","line_url":"/filing/0001225208-14-024738#line-1","is_derivative":false,"issuer_cik":"0000885725","issuer_name":"BOSTON SCIENTIFIC CORP","issuer_ticker":"BSX","issuer_name_source":null,"issuer_url":"/issuer/0000885725","owner_cik":"0001566083","owner_name":"Prange Karen","owner_display_name":"Prange Karen","owner_url":"/insider/0001566083","role":"Officer (SVP&Pres, Uro & Women's Health)","role_mark":"O","role_mark_label":"Officer (SVP&Pres, Uro & Women's Health)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP&Pres, Uro & Women's Health","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19753.0,"shares_display":"19,753","price_per_share":12.6364,"price_display":"12.64","price_state":"stated","total_value":249606.8092,"total_display":"249,606.81","total_whole":"249,607","shares_owned_after":17430.0,"shares_owned_after_display":"17,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001323885","name":"AtriCure, Inc.","url":"/issuer/0001323885","role":"Director","n_filings":4,"first_seen":"2023-06-12","last_seen":"2026-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001597313","name":"ViewRay, Inc.","url":"/issuer/0001597313","role":"Director","n_filings":2,"first_seen":"2022-05-12","last_seen":"2023-07-21"},{"type":"issuer","type_label":"ISSUER","cik":"0000885725","name":"BOSTON SCIENTIFIC CORP","url":"/issuer/0000885725","role":"Officer (SVP&Pres, Uro & Pelvic Health)","n_filings":6,"first_seen":"2014-12-10","last_seen":"2016-03-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001566083","retrieved_at":"2026-08-25T09:25:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}